Rare diseases
Investigational molecules
Locations
Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A
PolandStudy of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma
PolandStudy of MK-1045 alone or with Tocilizumab in patients with Non‑Hodgkin Lymphoma to evaluate safety and efficacy
PolandLong‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis
PolandA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
PolandEIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer
PolandNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
PolandLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
PolandEIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors
PolandAUR200 for Patients with Generalized Myasthenia Gravis
PolandStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
PolandQTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
